Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population
Abstract
:1. Introduction
2. Subjects and Methods
2.1. Subjects
2.2. Study Design: Cross-Sectional Study
2.2.1. Procedures
2.2.2. Sample Size
2.3. Ethical Considerations
2.4. Personal Variables
2.5. Psychological Variables
2.6. Laboratory Tests
2.7. Statistical Analysis
3. Results
3.1. Bivariate Analysis
3.2. Multivariate Regression Analysis
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Furman, D.; Campisi, J.; Verdin, E.; Carrera-Bastos, P.; Targ, S.; Franceschi, C.; Ferrucci, L.; Gilroy, D.W.; Fasano, A.; Miller, G.W.; et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019, 25, 1822–1832. [Google Scholar] [CrossRef]
- Liguori, I.; Russo, G.; Curcio, F.; Bulli, G.; Aran, L.; Della-Morte, D.; Gargiulo, G.; Testa, G.; Cacciatore, F.; Bonaduce, D.; et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 2018, 13, 757–772. [Google Scholar] [CrossRef]
- Friedman, E.M.; Ryff, C.D. Living Well with Medical Comorbidities: A Biopsychosocial Perspective. J. Gerontol. Ser. B Psychol. Sci. Soc. Sci. 2012, 67, 535–544. [Google Scholar] [CrossRef]
- Steptoe, A.; O’Donnell, K.; Badrick, E.; Kumari, M.; Marmot, M. Neuroendocrine and Inflammatory Factors Associated with Positive Affect in Healthy Men and Women: The Whitehall II Study. Am. J. Epidemiol. 2007, 167, 96–102. [Google Scholar] [CrossRef] [PubMed]
- Jones, D.R.; Graham-Engeland, J.E. Positive affect and peripheral inflammatory markers among adults: A narrative review. Psychoneuroendocrinology 2021, 123, 104892. [Google Scholar] [CrossRef]
- Tayefi, M.; Shafiee, M.; Kazemi-Bajestani, S.M.R.; Esmaeili, H.; Darroudi, S.; Khakpouri, S.; Mohammadi, M.; Ghaneifar, Z.; Azarpajouh, M.R.; Moohebati, M.; et al. Depression and anxiety both associate with serum level of hs-CRP: A gender-stratified analysis in a population-based study. Psychoneuroendocrinology 2017, 81, 63–69. [Google Scholar] [CrossRef]
- Pitharouli, M.C.; Hagenaars, S.P.; Glanville, K.P.; Coleman, J.R.; Hotopf, M.; Lewis, C.M.; Pariante, C.M. Elevated C-Reactive Protein in Patients with depression, Independent of Genetic, Health, and Psychosocial Factors: Results from the UK Biobank. Am. J. Psychiatry 2021, 178, 522–529. [Google Scholar] [CrossRef] [PubMed]
- Duivis, H.E.; Vogelzangs, N.; Kupper, N.; De Jonge, P.; Penninx, B.W. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: Findings from the Netherlands Study of Depression and Anxiety (NESDA). Psychoneuroendocrinology 2013, 38, 1573–1585. [Google Scholar] [CrossRef]
- Teixeira Silva, C.; Cândido, A.P.C.; Pala, D.; Oliveira Barbosa, P.; Machado-Coelho, G.L.L.; Pereira de Oliveira, F.L.; Pinheiro Volp, A.C.; Nascimento de Freitas, R. Clustered Cardiovascular Risk Factors Are Associated with Inflammatory Markers in Adolescents. Ann. Nutr. Metab. 2017, 70, 259–267. [Google Scholar] [CrossRef] [PubMed]
- Moutachakkir, M.; Lamrani Hanchi, A.; Baraou, A.; Boukhira, A.; Chellak, S. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein. Ann. Biol. Clin. 2017, 75, 225–229. [Google Scholar] [CrossRef]
- Sproston, N.R.; Ashworth, J.J. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front. Immunol. 2018, 9, 754. [Google Scholar] [CrossRef] [PubMed]
- Pearson, T.A.; Mensah, G.A.; Alexander, R.W.; Anderson, J.L.; Cannon, R.O., 3rd; Criqui, M.; Fadl, Y.Y.; Fortmann, S.P.; Hong, Y.; Myers, G.L.; et al. Centers for Disease Control and Prevention and the American Heart Association. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107, 499–511. [Google Scholar]
- Ironson, G.; Banerjee, N.; Fitch, C.; Krause, N. Positive emotional well-being, health Behaviors, and inflammation measured by C-Reactive protein. Soc. Sci. Med. 2018, 197, 235–243. [Google Scholar] [CrossRef] [PubMed]
- Liukkonen, T.; Räsänen, P.; Jokelainen, J.; Leinonen, M.; Järvelin, M.-R.; Meyer-Rochow, V.; Timonen, M. The association between anxiety and C-reactive protein (CRP) levels: Results from the Northern Finland 1966 Birth Cohort Study. Eur. Psychiatry 2011, 26, 363–369. [Google Scholar] [CrossRef] [PubMed]
- Camacho, L.; Larsen, B.; McClelland, R.L.; Morgan, C.; Criqui, M.H.; Cushman, M.; Allison, M.A. Association of subsyndromal and depressive symptoms with inflammatory markers among different ethnic groups: The multi-ethnic study of atherosclerosis (MESA). J. Affect. Disord. 2014, 164, 165–170. [Google Scholar] [CrossRef]
- Whooley, M.A.; Caska, C.M.; Hendrickson, B.E.; Rourke, M.A.; Ho, J.; Ali, S. Depression and Inflammation in Patients with Coronary Heart Disease: Findings from the Heart and Soul Study. Biol. Psychiatry 2007, 62, 314–320. [Google Scholar] [CrossRef]
- Díaz-Pértegas, S.; Pita-Fernández, S. Determinación del tamaño muestral para calcular la significación del coeficiente de correlación lineal. Cad. Aten. Primaria 2022, 9, 209–211. Available online: https://www.fisterra.com/gestor/upload/guias/pearson2.pdf (accessed on 4 March 2023).
- Bobes-García, J.; González, G.; Portilla, P.; Sáiz-Martínez, D.A.; Bascarán-Fdez, M.; Iglesias-Álvarez, G.; Fdez-Domínguez, J.M. Propiedades psicométricas del cuestionario de Oviedo de Sueño. Psicothema 2000, 12, 107–112. [Google Scholar]
- Bernal-Orozco, M.F.; Badillo-Camacho, N.; Macedo-Ojeda, G.; González-Gómez, M.; Orozco-Gutiérrez, J.F.; Prado-Arriaga, R.J.; Márquez-Sandoval, F.; Altamirano-Martínez, M.B.; Vizmanos, B. Design and Reproducibility of a Mini-Survey to Evaluate the Quality of Food Intake (Mini-ECCA) in a Mexican Population. Nutrients 2018, 10, 524. [Google Scholar] [CrossRef]
- Radloff, L. The CES-D Scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1, 385–401. [Google Scholar] [CrossRef]
- Bojorquez-Chapela, L.; Salgado de Snyder, N. Características psicométricas de la escala Center for Epidemiological Studies-Depression (CES-D), versiones de 20 y 10 reactivos en mujeres de una zona rural mexicana. Salud. Ment. 2009, 32, 297–307. [Google Scholar]
- Garcia-Campayo, J.; Zamorano, E.; Ruiz, M.A.; Pardo, A.; Perez-Paramo, M.; Lopez-Gomez, V.; Freire, O.; Rejas, J. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual. Life Outcomes 2010, 8, 8. [Google Scholar] [CrossRef]
- Cortina-Guzmán, L.G.; Berenzon-Gom, S. Traducción al español y propiedades picométricas del instrumento “positivity self test”. Psicol. Iberoam. 2013, 21, 53–64. [Google Scholar] [CrossRef]
- Diaz, D.; Rodriguez-Carvajal, R.; Blanco, A.; Moreno-Jimenez, B.; Gallardo, I.; Valle, C.; Van Dierendonck, D. Adaptación española de las escalas de bienestar psicológico de Ryff. Psicothema 2006, 18, 572–577. [Google Scholar] [PubMed]
- Ferrando, P.J.; Chico, E.; Tous, J.M. Propiedades psicométricas del test de Optimismo Life Orientation Test. Psicothema 2002, 14, 673–680. [Google Scholar]
- Chirumbolo, A.; Picconi, L.; Morelli, M.; Petrides, K.V. The Assessment of Trait Emotional Intelligence: Psychometric Characteristics of the TEIQue-Full Form in a Large Italian Adult Sample. Front. Psychol. 2019, 9, 2786. [Google Scholar] [CrossRef] [PubMed]
- Aguglia, A.; Natale, A.; Fusar-Poli, L.; Gnecco, G.B.; Lechiara, A.; Marino, M.; Meinero, M.; Pastorino, F.; Costanza, A.; Spedicato, G.A.; et al. C-Reactive Protein as a Potential Peripheral Biomarker for High-Lethality Suicide Attempts. Life 2022, 12, 1557. [Google Scholar] [CrossRef]
- Serafini, G.; Costanza, A.; Aguglia, A.; Amerio, A.; Trabucco, A.; Escelsior, A.; Sher, L.; Amore, M. The Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior. Med. Clin. N. Am. 2023, 107, 1–29. [Google Scholar] [CrossRef]
- Costanza, A.; Amerio, A.; Aguglia, A.; Serafini, G.; Amore, M.; Hasler, R.; Ambrosetti, J.; Bondolfi, G.; Sampogna, G.; Berardelli, I.; et al. Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision? Neurosci. Biobehav. Rev. 2022, 136, 104606. [Google Scholar] [CrossRef]
- Picard, M.; McManus, M.J.; Gray, J.D.; Nasca, C.; Moffat, C.; Kopinski, P.K.; Seifert, E.L.; McEwen, B.S.; Wallace, D.C. Mitochondrial functions modulate neuroendocrine, metabolic, inflammatory, and transcriptional responses to acute psychological stress. Proc. Natl. Acad. Sci. USA 2015, 112, E6614–E6623. [Google Scholar] [CrossRef]
- Allen, J.; Caruncho, H.J.; Kalynchuk, L.E. Severe life stress, mitochondrial dysfunction, and depressive behavior: A pathophysiological and therapeutic perspective. Mitochondrion 2021, 56, 111–117. [Google Scholar] [CrossRef]
- Janicki Deverts, D.; Cohen, S.; DiLillo, V.G.; Lewis, C.E.; Kiefe, C.; Whooley, M.; Matthews, K.A. Depressive Symptoms, Race, and Circulating C-Reactive Protein: The Coronary Artery Risk Development in Young Adults (CARDIA) Study. Psychosom. Med. 2010, 72, 734–741. [Google Scholar] [CrossRef] [PubMed]
- Kawai, T.; Autieri, M.V.; Scalia, R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am. J. Physiol. Cell Physiol. 2021, 320, C375–C391. [Google Scholar] [CrossRef]
- Kerner, A.; Avizohar, O.; Sella, R.; Bartha, P.; Zinder, O.; Markiewicz, W.; Levy, Y.; Brook, G.J.; Aronson, D. Association Between Elevated Liver Enzymes and C-Reactive Protein. Arter. Thromb. Vasc. Biol. 2005, 25, 193–197. [Google Scholar] [CrossRef]
- Banik, S.D.; Avila-Nava, A.; Lugo, R.; Chim Aké, R.; Gutiérrez Solis, A.L. Association Between Low-Grade Inflammation and Hyperuricemia in Adults with Metabolic Syndrome in Yucatán, México. Can. J. Diabetes 2021, 46, 369–374. [Google Scholar] [CrossRef] [PubMed]
- Chocano-Bedoya, P.O.; Mirzaei, F.; O’Reilly, E.J.; Lucas, M.; Okereke, O.I.; Hu, F.B.; Rimm, E.B.; Ascherio, A. C-reactive protein, interleukin-6, soluble tumor necrosis factor α receptor 2 and incident clinical depression. J. Affect. Disord. 2014, 163, 25–32. [Google Scholar] [CrossRef]
- Brambila-Tapia, A.J.L.; Macías-Espinoza, F.; Reyes-Domínguez, Y.A.; Ramírez-García, M.L.; Miranda-Lavastida, A.J.; Ríos-González, B.E.; Saldaña-Cruz, A.M.; Esparza-Guerrero, Y.; Mora-Moreno, F.F.; Dávalos-Rodríguez, I.P. Association of Depression, Anxiety, Stress and Stress-Coping Strategies with Somatization and Number of Diseases According to Sex in the Mexican General Population. Healthcare 2022, 10, 1048. [Google Scholar] [CrossRef]
- Nusslock, R.; Miller, G.E. Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis. Biol. Psychiatry 2016, 80, 23–32. [Google Scholar] [CrossRef] [PubMed]
- Meléndez-Monreal, K.C.; Brambila-Tapia, A.J.L.; González-Díaz, V.; Cerpa-Cruz, S.; Gutiérrez-Ureña, S.R.; Yeo-Ayala, M.d.C.; Robles-García, R.; Martínez-Bonilla, G.E. Association of possitive psychological variables with disease activity, functional disability and erythrocyte sedimentation rate in patients with rheumatoid arthritis: A preliminary study. Reumatismo 2022, 74, 168–175. [Google Scholar]
Variable | Global Sample (n = 172) | Women (n = 91) | Men (n = 81) |
---|---|---|---|
With romantic partner, n (%) | 89 (51.7) | 46 (50.5) | 43 (53.1) |
With children, n (%) | 35 (20.3) | 24 (26.4) | 11 (13.6) |
With job, n (%) | 89 (51.7) | 51 (56.0) | 38 (46.9) |
Schooling, n (%)
| 1 (0.6) 5 (2.9) 99 (57.5) 53 (30.8) 13 (7.6) 1 (0.6) | 1 (1.1) 3 (3.3) 48 (52.7) 32 (35.2) 7 (7.7) 0 (0.0) | 0 (0.0) 2 (2.5) 51 (63.0) 21 (25.9) 6 (7.4) 1 (1.2) |
Socioeconomic level, n (%)
| 2 (1.2) 32 (18.6) 133 (77.3) 5 (2.9) 0 (0.0) | 0 (0.0) 17 (18.7) 73 (80.2) 1 (1.1) 0 (0.0) | 2 (2.5) 15 (18.5) 60 (74.1) 4 (4.9) 0 (0.0) |
Monthly extra money, mean ± SD * | 3.06 ± 1.25 | 2.95 ± 1.17 | 3.19 ± 1.32 |
Smoking frequency, median (range) * | 0 (0–4) | 0 (0–4) | 0 (0–4) |
Alcohol consumption frequency, mean ± SD * | 1.45 ± 0.90 | 1.46 ± 0.87 | 1.44 ± 0.94 |
Daily free hours, median (range) * | 4 (0–14) | 4 (0–11) | 4 (0–14) |
Daily physical activity hours, median (range) * | 1 (0–5) | 1 (0–5) | 1 (0–4) |
Body mass index (BMI), mean ± SD | 24.38 ± 3.96 | 23.99 ± 3.73 | 24.82 ± 4.19 |
Waist to hip ratio (WHR), mean ± SD | 0.80 ± 0.07 | 0.77 ± 0.05 | 0.84 ± 0.07 |
Sleep satisfaction (OVIEDO scale), median (range) * | 4.03 ± 1.49 | 3.90 ± 1.45 | 4.17 ± 1.53 |
Sleep quality (OVIEDO scale), mean ± SD | 3.64 ± 0.95 | 3.57 ± 0.96 | 3.73 ± 0.93 |
Quality of food intake (Mini-ECCA scale), mean ± SD * | 7.47 ± 2.53 | 7.73± 2.65 | 7.17 ± 2.38 |
Psychological variables | |||
Anxiety (GAD-7), mean ± SD * | 1.06 ± 0.69 | 1.19 ± 0.74 | 0.90 ± 0.59 |
Depression (CES-D), mean ± SD * | 1.88 ± 0.53 | 1.94 ± 0.56 | 1.80 ± 0.47 |
Psychological wellbeing (PWB), mean ± SD
| 4.71 ± 1.15 4.11 ± 1.01 4.59 ± 1.18 4.81 ± 1.02 5.05 ± 0.94 4.42 ± 1.04 | 4.63 ± 1.19 3.92 ± 0.97 4.57 ± 1.19 4.89 ± 1±.04 5.12 ± 0.93 4.40 ± 1.08 | 4.79 ± 1.10 4.32 ± 1.02 4.61 ± 1.17 4.71 ± 0.98 4.98 ± 0.96 4.44 ± 1.01 |
Emotional intelligence (TIEQUE), mean ± SD
| 4.87 ± 1.05 4.93 ± 1.21 5.08 ± 1.19 4.98 ± 1.41 | 4.66 ± 0.96 4.85 ± 1.17 5.19 ± 1.17 4.92 ± 1.46 | 5.11 ± 1.10 5.03 ± 1.25 4.95 ± 1.21 5.05 ± 1.37 |
Positive emotions (PSS), mean ± SD | 3.73 ± 0.59 | 3.66 ± 0.64 | 3.81 ± 0.54 |
Negative emotions (PSS), mean ± SD * | 2.51 ± 0.62 | 2.60 ± 0.64 | 2.40 ± 0.59 |
Optimism (LOT-R), mean ± SD | 3.69 ± 0.71 | 3.68 ± 0.74 | 3.68 ± 0.68 |
Variable | Women (n = 91) | Men (n = 81) | Laboratory Reference Values | Participants Out of Range n (%) |
---|---|---|---|---|
hs-CRP (mg/L), median (range) * | 0.95 (0.12–11.57) | 0.85 (0.14–36.00) | ≤3.0 | 31 (18.0) |
Leukocytes (103/μL), mean ± SD
| 6.80 ± 1.48 2.23 ± 0.53 0.49 ± 0.14 3.88 ± 1.18 0.14 ± 0.12 0.04 ± 0.02 | 6.58 ±1.81 2.17 ± 0.55 0.53 ± 0.16 3.68 ± 1.44 0.13 ± 0.09 0.05 ± 0.02 | 5.0–10.00 1.0–4.20 0.10–1.00 1.50–7.00 0.05–0.40 0.01–0.05 | 28 (16.3) 1 (0.6) 1 (0.6) 4 (2.3) 21 (12.2) 42 (24.4) |
Hemoglobin (g/dL), mean ± SD | 13.83 ± 1.14 | 16.25 ± 0.99 | W: 12.00–16.00 M: 14.00–17.00 | 7 (7.7) 17 (21.0) |
Platelets (103/μL), mean ± SD | 276.47 ± 53.05 | 261.48 ± 52.30 | 141.00–400.00 | 3 (1.7) |
Glucose (g/dL), mean ± SD | 87.33 ± 8.58 | 89.52 ± 7.86 | 74.00–106.00 | 11 (6.4) |
Urea (mg/dL), mean ± SD * | 25.49 ± 6.57 | 28.38 ± 7.04 | 16.6–48.5 | 6 (3.5) |
Blood urea nitrogen (BUN), mg/dL, mean ± SD * | 11.91 ± 3.07 | 13.26 ± 3.29 | 6.0–20.0 | 8 (4.7) |
Creatinine (mg/dL), mean ± SD | 0.74 ± 0.11 | 0.95 ± 0.13 | W: 0.50–0.90 M: 0.70–1.20 | 8 (8.8) 4 (5.0) |
Uric acid (mg/dL) mean ± SD | 4.22 ± 0.99 | 6.02 ± 1-12 | W: 2.4–5.7 M: 3.4–7.0 | 7 (7.7) 14 (17.3) |
Lipid levels (mg/dL), mean ± SD
| 165.97 ± 29.26 52.01 ± 11.74 95.40 ± 24.32 92.77 ± 43.73 | 176.55 ± 36.23 44.63 ± 10.29 108.85 ± 29.53 118.65 ± 68.93 | ≤200.00 W ≥ 45.00, M ≥ 35.00 ≤100.00 ≤150.00 | 36 (20.9) 31 (34.1), 13 (16.0) 82 (47.7) 34 (19.8) |
Bilirubin (mg/dL), mean ± SD
| 0.48 ± 0.28 0.20 ± 0.08 0.29 ± 0.20 | 0.72 ± 0.36 0.26 ± 0.10 0.46 ± 0.27 | ≤ 1.20 ≤ 0.30 0.10–1.00 | 9 (5.2) 27 (15.7) 9 (5.2) |
Liver enzymes (U/L), mean ± SD
| 20.05 ± 16.08 17.55 ± 15.43 16.16 ± 7.61 78.58 ± 17.59 169.69 ± 31.89 | 29.70 ± 39.57 28.66± 21.19 27.40 ± 22.47 97.26 ± 26.88 186.31 ±100.56 | W ≤ 32.00, M ≤ 40.00 W ≤ 33.00, M ≤ 41.00 W ≤ 40.00, M ≤ 60.00 W ≤ 104.00, M ≤ 129.00 W ≤ 214.00, M ≤ 225.00 | 4 (4.4), 7 (8.6) 6 (6.5), 11 (13.6) 2 (2.2), 4 (4.9) 5 (5.5), 12 (14.8) 4 (4.4), 5 (6.2) |
Urine exam, median (range)
| 0 (0–500) 0 (0–1) 0 (0–20) | 0 (0–100) 0 (0–0) 0 (0–20) | 0 0 0 | 50 (29.1) 4 (2.3) 67 (39.0) |
Variable | Women (n = 91) | Men (n = 81) | Global Sample (n = 172) |
---|---|---|---|
Age | 0.248 * | 0.147 | 0.222 ** |
Schooling | 0.184 | 0.134 | 0.166 * |
With children | 0.213 * | 0.189 | 0.225 ** |
With job | 0.252 * | 0.151 | 0.217 ** |
Body mass index (BMI) | 0.544 ** | 0.396 ** | 0.489 ** |
Waist/hip ratio (WHR) | 0.299 ** | 0.413 ** | 0.240 ** |
Leukocytes | 0.343 ** | 0.439 ** | 0.375 ** |
Erythrocytes | 0.130 | 0.213 * | 0.063 |
Platelets | 0.226 * | 0.230 * | 0.237 ** |
Lymphocytes | 0.117 | 0.348 ** | 0.217 ** |
Monocytes | 0.245 * | 0.291 ** | 0.250 ** |
Eosinophils | 0.209* | 0.163 | 0.178 * |
Neutrophils | 0.343 ** | 0.368 ** | 0.341 ** |
Uric acid | 0.398 ** | 0.292 ** | 0.201 ** |
Cholesterol | 0.239 * | 0.141 | 0.188 * |
Triglycerides | 0.475 ** | 0.316 ** | 0.386 ** |
High-density lipoprotein (HDL) | −0.351 ** | −0.494 ** | −0.359 ** |
Low-density lipoprotein (LDL) | 0.295 ** | 0.173 | 0.223 ** |
Gamma glutamyl transferase (GGT) | 0.458 ** | 0.379 ** | 0.342 ** |
Alkaline phosphatase (ALP) | 0.365 ** | 0.294 ** | 0.282 ** |
lactate dehydrogenase (LDH) | 0.080 | 0.329 ** | 0.186 * |
Erythrocytes in urine | 0.256 ** | 0.201 | 0.237 ** |
Variable | B | Beta Coefficient | Significance | Tolerance | Change in R2 |
---|---|---|---|---|---|
Constant | −17.889 | - | 0.000 | - | - |
Waist/hip ratio (WHR) | 24.704 | 0.456 | 0.000 | 0.543 | 0.135 |
Sex | −3.095 | −0.413 | 0.000 | 0.454 | 0.050 |
Monocytes | 5.473 | 0.219 | 0.001 | 0.911 | 0.051 |
Alcohol consumption frequency | 1.276 | 0.306 | 0.000 | 0.866 | 0.053 |
Uric acid | 0.576 | 0.214 | 0.015 | 0.482 | 0.029 |
Anxiety (GAD-7) | 1.974 | 0.364 | 0.000 | 0.363 | 0.016 |
Schooling | −0.726 | −0.140 | 0.038 | 0.824 | 0.014 |
Emotional regulation | 0.712 | 0.231 | 0.001 | 0.735 | 0.019 |
Daily free hours | 0.194 | 0.131 | 0.045 | 0.876 | 0.011 |
Erythrocytes in urine | 0.150 | 0.122 | 0.057 | 0.905 | 0.011 |
Positive relations with others | −0.628 | −0.172 | 0.021 | 0.667 | 0.013 |
Depression (CES-D) | −2.191 | −0.310 | 0.003 | 0.340 | 0.016 |
Variable | B | Beta Coefficient | Significance | Tolerance | Change in R2 |
---|---|---|---|---|---|
Constant | −10.685 | - | 0.000 | - | - |
Neutrophils | 0.799 | 0.391 | 0.000 | 0.931 | 0.265 |
Uric acid | 0.469 | 0.188 | 0.013 | 0.848 | 0.133 |
Body mass index (BMI) | 0.190 | 0.284 | 0.000 | 0.894 | 0.078 |
Erythrocytes in urine | 0.177 | 0.251 | 0.001 | 0.884 | 0.076 |
Alkaline phosphatase (ALP) | 0.024 | 0.174 | 0.016 | 0.927 | 0.035 |
Alcohol consumption frequency | 0.521 | 0.187 | 0.009 | 0.928 | 0.028 |
Leukocyte esterase | 0.002 | 0.125 | 0.087 | 0.883 | 0.014 |
Variable | B | Beta Coefficient | Significance | Tolerance | Change in R2 |
---|---|---|---|---|---|
Constant | −27.014 | - | 0.000 | - | - |
Waist/hip ratio (WHR) | 43.430 | 0.628 | 0.000 | 0.507 | 0.248 |
Leukocytes in urine | 1.262 | 0.279 | 0.001 | 0.819 | 0.045 |
Emotional regulation | 1.048 | 0.273 | 0.001 | 0.882 | 0.035 |
Sleep satisfaction | −1.220 | −0.384 | 0.000 | 0.654 | 0.033 |
Schooling | −1.667 | −0.244 | 0.006 | 0.703 | 0.045 |
Monocytes | 4.826 | 0.161 | 0.047 | 0.824 | 0.023 |
Depression (CES-D) | −6.330 | −0.625 | 0.000 | 0.349 | 0.027 |
Anxiety (GAD-7) | 4.329 | 0.534 | 0.000 | 0.437 | 0.078 |
With job | −2.460 | −0.255 | 0.005 | 0.693 | 0.027 |
Lymphocytes | 1.795 | 0.204 | 0.022 | 0.696 | 0.019 |
Triglycerides | −0.014 | −0.201 | 0.041 | 0.563 | 0.023 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Brambila-Tapia, A.J.L.; Jacquez-Castañeda, A.L.; Carrillo-Delgadillo, L.A.; Dávila-Flores, J.N.; Macías-Espinoza, F.; Ramírez-De Los Santos, S.; Gutiérrez-Hurtado, I.A. Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population. J. Pers. Med. 2023, 13, 876. https://doi.org/10.3390/jpm13050876
Brambila-Tapia AJL, Jacquez-Castañeda AL, Carrillo-Delgadillo LA, Dávila-Flores JN, Macías-Espinoza F, Ramírez-De Los Santos S, Gutiérrez-Hurtado IA. Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population. Journal of Personalized Medicine. 2023; 13(5):876. https://doi.org/10.3390/jpm13050876
Chicago/Turabian StyleBrambila-Tapia, Aniel Jessica Leticia, Ana Lilia Jacquez-Castañeda, Laura Arely Carrillo-Delgadillo, Jessica Natalia Dávila-Flores, Fabiola Macías-Espinoza, Saúl Ramírez-De Los Santos, and Itzae Adonai Gutiérrez-Hurtado. 2023. "Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population" Journal of Personalized Medicine 13, no. 5: 876. https://doi.org/10.3390/jpm13050876
APA StyleBrambila-Tapia, A. J. L., Jacquez-Castañeda, A. L., Carrillo-Delgadillo, L. A., Dávila-Flores, J. N., Macías-Espinoza, F., Ramírez-De Los Santos, S., & Gutiérrez-Hurtado, I. A. (2023). Association between Psychological, Biochemical and Personal Factors with the Inflammatory Marker High-Sensitive C Reactive Protein (Hs-CRP) in Mexican Healthy Population. Journal of Personalized Medicine, 13(5), 876. https://doi.org/10.3390/jpm13050876